Platelet activation, haemorheology and thrombogenesis in acute atrial fibrillation: A comparison with permanent atrial fibrillation

Heart

Volumn 89, Issue 9, 2003, Pages 1093-1095

  Kamath, S ^a   Blann, A D ^a   Chin, Bernard S P ^a   Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; D DIMER; PADGEM PROTEIN; WARFARIN;

ADULT; AGED; ARTICLE; BLOOD RHEOLOGY; BLOOD SAMPLING; BLOOD VISCOSITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEMATOCRIT; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINUS RHYTHM; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOGENESIS;

EID: 0041326759     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.89.9.1093     Document Type: Article

References (18)

1. Stoddard MF. Risk of thromboembolism in acute atrial fibrillation or atrial flutter. Echocardiography 2000;17:393-405.
2. Lip GYH, Hart RG, Conway DSG. ABC of antithrombotic therapy. Antithrombotic therapy for atrial fibrillation. BMJ 2002;325:1022-5.
3. Oltrona L, Broccolino M, Merlini PA, et al. Activation of the hemostatic mechanism after pharmacological cardioversion of acute nonvalvular atrial fibrillation. Circulation 1997;95:2003-6.
4. Lip GYH. Does atrial fibrillation confer a hypercoagulable state? Lancet 1995;346:1313-4.
5. Li-Saw-Hee FL, Blann AD, Gurney D, et al. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function. Eur Heart J 2001;22:1741-7.
6. Sohara H, Miyahara K. Effect of atrial fibrillation on the fibrino-coagulation system - study in patients with paroxysmal atrial fibrillation. Jpn Circ J 1994;58:821-6.
7. Takahashi N, Ashida T, Kiraku J, et al. Increase in erythrocyte volume in patients with chronic atrial fibrillation. Jpn Heart J 1997;38:387-91.
8. Okuno S, Ashida T, Ebihara A, et al. Distinct increase in hematocrit associated with paroxysm of atrial fibrillation. Jpn Heart J 2000;41:617-22.
9. Yamada H, Sugiyama T, Ashida T, et al. Sustained hemoconcentration in patients with chronic atrial fibrillation, a potential risk for stroke and thromboembolic complications. A retrospective study. Jpn Heart J 1998;39:715-20.
10. Hornestam B, Hall C, Held P, et al. N-terminal proANF in acute atrial fibrillation: a biochemical marker of atrial pressures but not a predictor for conversion to sinus rhythm. Digitalis in acute atrial fibrillation (DAAF) trial group. Am Heart J 1998;135:1040-7.
11. Roy D, Paillard F, Cassidy D, et al. Atrial natriuretic factor during atrial fibrillation and supraventricular tachycardia. J Am Coll Cardiol 1987;9:509-14.
12. Petersen P, Kastrup J, Vilhelmsen R, et al. Atrial natriuretic peptide in atrial fibrillation before and after electrical cardioversion therapy. Eur Heart J 1988;9:639-41.
13. Hwang JJ, Ko FN, Li YH, et al. Clinical implications and factors related to left atrial spontaneous echo contrast in chronic nonvalvular atrial fibrillation. Cardiology 1994;85:69-75.
14. Yasaka M, Yamaguchi T, Oita J, et al. Clinical features of recurrent embolization in acute cardioembalic stroke. Stroke 1993;24:1681-5.
15. Lowe GD, Jaap AJ, Forbes CD. Relation of atrial fibrillation and high haematocrit to mortality in acute stroke. Lancet 1983;i:784-6.
16. Van Den Berg MP, Crijns HJ, Van Veldhuisen DJ, et al. Atrial natriuretic peptide in patients with heart failure and chronic atrial fibrillation: role of duration of atrial fibrillation. Am Heart J 1998;135:242-4.
17. Kamath S, Blann AD, Lip GYH. Platelet activation in atrial fibrillation. Eur Heart J 2001;22:2233-42.
18. One N, Koyama T, Suehiro A, et al. Influence of atrial fibrillation on coagulo-fibrinolytic markers in patients with cerebral infarction. Int Angiol 1992;11:298-303.